Scientist identify first-ever likely treatments for deadly ‘MERS’
Scientists have identified the first-ever possible treatments for deadly virus Middle East Respiratory Syndrome (MERS).
University of Maryland School of Medicine and Regeneron Pharmaceuticals, Inc., scientists have found and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 percent.
These therapeutics are the first to succeed in protecting and treating animal models of the MERS virus.